Barclays’s Cassava Sciences SAVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5K | Sell |
2,734
-41,396
| -94% | -$75.7K | ﹤0.01% | 4215 |
|
2025
Q1 | $66K | Sell |
44,130
-49,449
| -53% | -$74K | ﹤0.01% | 3817 |
|
2024
Q4 | $221K | Buy |
93,579
+18,832
| +25% | +$44.5K | ﹤0.01% | 3467 |
|
2024
Q3 | $2.2M | Buy |
74,747
+53,487
| +252% | +$1.57M | ﹤0.01% | 2112 |
|
2024
Q2 | $264K | Sell |
21,260
-30,098
| -59% | -$374K | ﹤0.01% | 2892 |
|
2024
Q1 | $1.04M | Sell |
51,358
-54,232
| -51% | -$1.1M | ﹤0.01% | 2380 |
|
2023
Q4 | $2.38M | Buy |
105,590
+78,888
| +295% | +$1.78M | ﹤0.01% | 2040 |
|
2023
Q3 | $445K | Buy |
26,702
+6,711
| +34% | +$112K | ﹤0.01% | 2611 |
|
2023
Q2 | $489K | Sell |
19,991
-12,510
| -38% | -$306K | ﹤0.01% | 2611 |
|
2023
Q1 | $783K | Sell |
32,501
-11,155
| -26% | -$269K | ﹤0.01% | 2308 |
|
2022
Q4 | $1.29M | Buy |
43,656
+22,114
| +103% | +$653K | ﹤0.01% | 1936 |
|
2022
Q3 | $901K | Buy |
21,542
+902
| +4% | +$37.7K | ﹤0.01% | 2211 |
|
2022
Q2 | $581K | Sell |
20,640
-3,621
| -15% | -$102K | ﹤0.01% | 2473 |
|
2022
Q1 | $901K | Sell |
24,261
-86,747
| -78% | -$3.22M | ﹤0.01% | 2396 |
|
2021
Q4 | $4.85M | Buy |
111,008
+54,207
| +95% | +$2.37M | ﹤0.01% | 1255 |
|
2021
Q3 | $3.53M | Buy |
56,801
+51,960
| +1,073% | +$3.22M | ﹤0.01% | 1456 |
|
2021
Q2 | $414K | Sell |
4,841
-22,491
| -82% | -$1.92M | ﹤0.01% | 2571 |
|
2021
Q1 | $1.23M | Buy |
27,332
+16,718
| +158% | +$751K | ﹤0.01% | 2189 |
|
2020
Q4 | $72K | Sell |
10,614
-66
| -0.6% | -$448 | ﹤0.01% | 3070 |
|
2020
Q3 | $122K | Sell |
10,680
-18,602
| -64% | -$212K | ﹤0.01% | 2960 |
|
2020
Q2 | $91K | Buy |
+29,282
| New | +$91K | ﹤0.01% | 3161 |
|
2013
Q4 | – | Sell |
-135
| Closed | -$2K | – | 4404 |
|
2013
Q3 | $2K | Sell |
135
-7,610
| -98% | -$113K | ﹤0.01% | 3978 |
|
2013
Q2 | $120K | Buy |
+7,745
| New | +$120K | ﹤0.01% | 2945 |
|